PTA Balloon Catheter combines angioplasty and targeted injection
system in one device
LIMERICK, Pa.--(BUSINESS WIRE)--Jul. 30, 2013--
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical
devices for critical care and surgery, has announced that its subsidiary
Hotspur Technologies, Inc., which Teleflex acquired in June 2012,
received FDA 510(k) clearance to market the company’s ARROW®
GPSCath® Balloon Dilatation Catheters in Higher Rated Burst
Pressure (RBP) and 80 cm lengths. These novel products enable multiple
vascular procedures to be performed with one dual-function catheter,
potentially reducing procedure time and expense for both patients and
medical professionals.
The ARROW® GPSCath® Catheter is the first
dual-functional balloon dilatation catheter that combines angioplasty
and the proprietary VisioValve™ Injection System. This innovative
combination enables physicians to perform high-pressure angioplasty and
inject physician-specified fluids, such as contrast, all while
maintaining the guidewire position.
“We are committed to enabling medical professionals to perform
peripheral access procedures with devices that both simplify and improve
the doctors’ and patients’ experiences,” said Benson Smith, Chairman,
President and CEO of Teleflex. Added Smith, “There are approximately 20
million patients with peripheral vascular disease who could benefit from
this multi-purpose approach to catheter design, and we are excited to
bring this innovative peripheral access product to market. The ARROW®
GPSCath® Balloon Dilatation Catheter with VisioValve™
Technology is setting a higher bar for peripheral and dialysis access
angioplasty performance.”
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 11,700 people worldwide and serves
healthcare providers in more than 140 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, GPSCath and VisioValve are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates. © 2013 Teleflex
Incorporated. All rights reserved. 2013-2203
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836